#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroid melanoma Langerhans cell sarcoma Non-small cell lung cancer Philadelphia positive acute lymphocytic leukaemia Fibrodysplasia ossificans progressiva Sjogren's syndrome Thrombotic microangiopathy Acquired ATTR amyloidosis Mastocytosis Thermal burn Alveolar rhabdomyosarcoma Plasma cell myeloma refractory Cytokine release syndrome MELAS syndrome Acute graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome Pemphigus Toxic epidermal necrolysis – Treatment Fabry’s disease – Diagnostics Ewing’s sarcoma recurrent – Basic Information Wiskott-Aldrich syndrome Leiomyosarcoma metastatic – Treatment Rhabdomyosarcoma Lymphatic malformation – Basic Information Ocular melanoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dutasteride Siltuximab Nebivolol Hydrochloride Diclofenac Diethylamine Ibrutinib Dexrazoxane OSIMERTINIB MESYLATE Gentamicin Sulfate Maridebart Cafraglutide Ertapenem Sodium Lolium Perenne Ezetimibe Avacopan Ephedrine Hydrochloride Iberdomide IDOR-1117-2520C Dazukibart Misoprostol Amoxicillin Sodium GSKVX000000017986 More therapies…

    Learn about Your Condition

    Malignant oligodendroglioma Psoriasis Cerebral haemorrhage Peripheral ischaemia Prader-Willi syndrome Pleural mesothelioma Myasthenia gravis Cervix carcinoma stage IV Sinusitis bacterial Splenic marginal zone lymphoma Complex regional pain syndrome Malformation venous Ventricular fibrillation Erdheim-Chester disease Cardiac valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Ritonavir
    • Rosuvastatin Calcium
    • Nirmatrelvir
    Belgium

  • Effect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Ethinylestradiol
    • Iclepertin
    • Levonorgestrel
    Germany

  • Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan
    • Panitumumab
    • Bevacizumab
    Portugal Spain

  • Evaluation of the Efficacy, Safety, and Tolerability of Subcutaneous REGN7999 in Adults with Iron Overload Due to Non-Transfusion Dependent Beta-Thalassemia

    Not recruiting

    2 1
    Investigated Drugs:
    • REGN7999
    Greece Italy

  • Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial

    Not recruiting

    3 1
    Investigated Drugs:
    • Odevixibat
    Belgium France Germany Hungary Italy The Netherlands +2

  • Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cobolimab
    • Dostarlimab
    • Docetaxel
    Belgium Finland France Germany Greece Italy +5
Previous Page
1 … 919 920 921 922 923 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!